For some groups traditionally considered to be 'high risk', the evidence of an increased risk of severe influenza-associated illness is poor quality. by Horby, P, Horby, P

Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins. by Horby, P

Determining risk factors for infection with influenza A (H5N1) - Response by Horby, P

H7N9 is a virus worth worrying about. by Horby, P

Rendering beef safe. by Horby, P

Systematic review and meta-analysis: For some groups traditionally considered to be 'high risk', the evidence of an increased risk of severe influenza-associated illness is poor qu... by Horby, P

Why preprints are good for patients by Horby, P

Why are so few people infected with influenza A (H5N1) despite a large exposed population? The role of host genetics by Horby, P

Community studies of influenza: New knowledge, new questions by Horby, P

Community studies of influenza: new knowledge, new questions by Horby, P

Improving preparedness for the next flu pandemic by Horby, P

The global war on terrorism. by Horby, P

Modernising epidemic science: enabling patient-centred research during epidemics by Rojek, A, Horby, P

GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic. by Whitehead, J, Horby, P

The breadth of viruses in human semen by Salam, A, Horby, P

Isolation of viable Zika virus from spermatozoa. by Salam, A, Horby, P

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections by Rojek, A, Horby, P

International biological reference preparations for emerging infectious diseases: vital tools in epidemic preparedness by Rampling, T, Page, M, Horby, P

Person-to-person transmission of influenza A (H5N1). by Nguyen, T, Farrar, J, Horby, P

International biological reference preparations for epidemic infectious diseases by Rampling, T, Page, M, Horby, P